Loading…
Reported covered position: Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Doris Matsui (D-CA)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Removing Barriers to Allergy Diagnostic Testing Act of 2019
Client: BLUEBIRD STRATEGIES (ON BEHALF OF THERMO FISHER SCIENTIFIC) · Firm: FAEGRE BAKER DANIELS CONSULTING
Asthma policies and diagnostic allergy test coverage; H.R. 2009 Removing Barriers to Allergy Diagnostic Testing Act of 2019; S. 2246 Allergy Testing Access Act of 2019
Removing Barriers to Allergy Diagnostic Testing Act of 2019
Client: BLUEBIRD STRATEGIES (ON BEHALF OF THERMO FISHER SCIENTIFIC) · Firm: FAEGRE BAKER DANIELS CONSULTING
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE BAKER DANIELS CONSULTING
2020 · first_quarter · 1T
Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs
Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Source: Senate LDA
| THERMO FISHER SCIENTIFIC |
| 6 |
| 2018–2019 |
| UNDERWRITERS LABORATORIES | 5 | 2018–2019 |
| BLUEBIRD STRATEGIES (ON BEHALF OF THERMO FISHER SCIENTIFIC) | 3 | 2019–2020 |
| GLOBAL DOWN SYNDROME FOUNDATION | 2 | 2019–2020 |
| PARENT PROJECT MUSCULAR DYSTROPHY | 1 | 2020 |
Asthma policies and diagnostic allergy test coverage; H.R. 2009 Removing Barriers to Allergy Diagnostic Testing Act of 2019; S. 2246 Allergy Testing Access Act of 2019
Preserving Patient Access to Home Infusion Act
Client: IMMUNE DEFICIENCY FOUNDATION · Firm: FAEGRE BAKER DANIELS CONSULTING
Access to in-home IVIG including around current IVIG Bundled Payment Demonstration; S. 3457 and H.R. 6218 - Preserving Patient Access to Home Infusion Act; COVID-19 response and beneficiary access to care as a result of the emergency
Allergy Testing Access Act of 2019
Client: BLUEBIRD STRATEGIES (ON BEHALF OF THERMO FISHER SCIENTIFIC) · Firm: FAEGRE BAKER DANIELS CONSULTING
Asthma policies and diagnostic allergy test coverage; H.R. 2009 Removing Barriers to Allergy Diagnostic Testing Act of 2019; S. 2246 Allergy Testing Access Act of 2019
Allergy Testing Access Act of 2019
Client: BLUEBIRD STRATEGIES (ON BEHALF OF THERMO FISHER SCIENTIFIC) · Firm: FAEGRE BAKER DANIELS CONSULTING
Asthma policies and diagnostic allergy test coverage; H.R. 2009 Removing Barriers to Allergy Diagnostic Testing Act of 2019; S. 2246 Allergy Testing Access Act of 2019
Preserving Patient Access to Home Infusion Act
Client: IMMUNE DEFICIENCY FOUNDATION · Firm: FAEGRE BAKER DANIELS CONSULTING
Access to in-home IVIG including around current IVIG Bundled Payment Demonstration; S. 3457 and H.R. 6218 - Preserving Patient Access to Home Infusion Act; COVID-19 response and beneficiary access to care as a result of the emergency
SUPPORT for Patients and Communities Act
Client: NATIONAL COUNCIL FOR BEHAVIORAL HEALTH · Firm: FAEGRE BAKER DANIELS CONSULTING
Ryan Haight Online Pharmacy Consumer Protection Act; H.R.6 SUPPORT for Patients and Communities Act
Removing Barriers to Allergy Diagnostic Testing Act of 2019
Client: BLUEBIRD STRATEGIES (ON BEHALF OF THERMO FISHER SCIENTIFIC) · Firm: FAEGRE BAKER DANIELS CONSULTING
Asthma policies and diagnostic allergy test coverage; H.R. 2009 Removing Barriers to Allergy Diagnostic Testing Act of 2019; S. 2246 Allergy Testing Access Act of 2019
Removing Barriers to Allergy Diagnostic Testing Act of 2019
Client: BLUEBIRD STRATEGIES (ON BEHALF OF THERMO FISHER SCIENTIFIC) · Firm: FAEGRE BAKER DANIELS CONSULTING
Asthma policies and diagnostic allergy test coverage; H.R. 2009 Removing Barriers to Allergy Diagnostic Testing Act of 2019; S. 2246 Allergy Testing Access Act of 2019
Removing Barriers to Allergy Diagnostic Testing Act of 2019
Client: BLUEBIRD STRATEGIES (ON BEHALF OF THERMO FISHER SCIENTIFIC) · Firm: FAEGRE BAKER DANIELS CONSULTING
Asthma policies and diagnostic allergy test coverage; H.R. 2009 Removing Barriers to Allergy Diagnostic Testing Act of 2019; S. 2246 Allergy Testing Access Act of 2019
Removing Barriers to Allergy Diagnostic Testing Act of 2019
Client: BLUEBIRD STRATEGIES (ON BEHALF OF THERMO FISHER SCIENTIFIC) · Firm: FAEGRE BAKER DANIELS CONSULTING
Asthma policies and diagnostic allergy test coverage; H.R. 2009 Removing Barriers to Allergy Diagnostic Testing Act of 2019; S. 2246 Allergy Testing Access Act of 2019
Newborn Screening Saves Lives Reauthorization Act of 2019
Client: IMMUNE DEFICIENCY FOUNDATION · Firm: FAEGRE BAKER DANIELS CONSULTING
HR 2507 - Newborn Screening Saves Lives Reauthorization Act of 2019; Vaccine policy.
Newborn Screening Saves Lives Reauthorization Act of 2019
Client: IMMUNE DEFICIENCY FOUNDATION · Firm: FAEGRE BAKER DANIELS CONSULTING
HR 2507 - Newborn Screening Saves Lives Reauthorization Act of 2019; Vaccine policy.
Newborn Screening Saves Lives Reauthorization Act of 2019
Client: IMMUNE DEFICIENCY FOUNDATION · Firm: FAEGRE BAKER DANIELS CONSULTING
HR 2507 - Newborn Screening Saves Lives Reauthorization Act of 2019; Vaccine policy.
American Dream and Promise Act of 2019
Client: NATIONAL COUNCIL FOR BEHAVIORAL HEALTH · Firm: FAEGRE BAKER DANIELS CONSULTING
Ryan Haight Online Pharmacy Consumer Protection Act; H.R. 6 SUPPORT Act
American Dream and Promise Act of 2019
Client: NATIONAL COUNCIL FOR BEHAVIORAL HEALTH · Firm: FAEGRE BAKER DANIELS CONSULTING
Ryan Haight Online Pharmacy Consumer Protection Act; H.R. 6 SUPPORT Act
American Dream and Promise Act of 2019
Client: NATIONAL COUNCIL FOR BEHAVIORAL HEALTH · Firm: FAEGRE BAKER DANIELS CONSULTING
Ryan Haight Online Pharmacy Consumer Protection Act; H.R. 6 SUPPORT Act
American Dream and Promise Act of 2019
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE BAKER DANIELS CONSULTING
Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs: H.R. 6 SUPPORT Act
American Dream and Promise Act of 2019
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE BAKER DANIELS CONSULTING
Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs: H.R. 6 SUPPORT Act
American Dream and Promise Act of 2019
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE BAKER DANIELS CONSULTING
Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs: H.R. 6 SUPPORT Act
Allergy Testing Access Act of 2019
Client: BLUEBIRD STRATEGIES (ON BEHALF OF THERMO FISHER SCIENTIFIC) · Firm: FAEGRE BAKER DANIELS CONSULTING
Asthma policies and diagnostic allergy test coverage; H.R. 2009 Removing Barriers to Allergy Diagnostic Testing Act of 2019; S. 2246 Allergy Testing Access Act of 2019
Allergy Testing Access Act of 2019
Client: BLUEBIRD STRATEGIES (ON BEHALF OF THERMO FISHER SCIENTIFIC) · Firm: FAEGRE BAKER DANIELS CONSULTING
Asthma policies and diagnostic allergy test coverage; H.R. 2009 Removing Barriers to Allergy Diagnostic Testing Act of 2019; S. 2246 Allergy Testing Access Act of 2019
Allergy Testing Access Act of 2019
Client: BLUEBIRD STRATEGIES (ON BEHALF OF THERMO FISHER SCIENTIFIC) · Firm: FAEGRE BAKER DANIELS CONSULTING
Asthma policies and diagnostic allergy test coverage; H.R. 2009 Removing Barriers to Allergy Diagnostic Testing Act of 2019; S. 2246 Allergy Testing Access Act of 2019
Allergy Testing Access Act of 2019
Client: BLUEBIRD STRATEGIES (ON BEHALF OF THERMO FISHER SCIENTIFIC) · Firm: FAEGRE BAKER DANIELS CONSULTING
Asthma policies and diagnostic allergy test coverage; H.R. 2009 Removing Barriers to Allergy Diagnostic Testing Act of 2019; S. 2246 Allergy Testing Access Act of 2019
SUPPORT for Patients and Communities Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE BAKER DANIELS CONSULTING
Medication safety, pharmacy regulation, and the opioid epidemic; Pharmacy regulation; Prescription drug monitoring programs; H.R.6 SUPPORT for Patients and Communities Act
SUPPORT for Patients and Communities Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE BAKER DANIELS CONSULTING
Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs: H.R.6 SUPPORT for Patients and Communities Act
SUPPORT for Patients and Communities Act
Client: NATIONAL COUNCIL FOR BEHAVIORAL HEALTH · Firm: FAEGRE BAKER DANIELS CONSULTING
Ryan Haight Online Pharmacy Consumer Protection Act; H.R.6 SUPPORT for Patients and Communities Act
Protecting Access to Medicare Act of 2014
Client: MYRIAD GENETICS, INC. · Firm: FAEGRE BAKER DANIELS CONSULTING
PL 113-93 (H.R. 4302) - Protecting Access to Medicare Act of 2014; Implementation of changes to Medicare payment for clinical laboratory tests.
Protecting Access to Medicare Act of 2014
Client: MYRIAD GENETICS, INC. · Firm: FAEGRE BAKER DANIELS CONSULTING
PL 113-93 (H.R. 4302) - Protecting Access to Medicare Act of 2014; Implementation of changes to Medicare payment for clinical laboratory tests.
Protecting Access to Medicare Act of 2014
Client: MYRIAD GENETICS, INC. · Firm: FAEGRE BAKER DANIELS CONSULTING
PL 113-93 (H.R. 4302) - Protecting Access to Medicare Act of 2014; Implementation of changes to Medicare payment for clinical laboratory tests.
Protecting Access to Medicare Act of 2014
Client: MYRIAD GENETICS, INC. · Firm: FAEGRE BAKER DANIELS CONSULTING
PL 113-93 (H.R. 4302) - Protecting Access to Medicare Act of 2014; Implementation of changes to Medicare payment for clinical laboratory tests.
Energy Star Program Integrity Act
Client: UNDERWRITERS LABORATORIES · Firm: FAEGRE BAKER DANIELS CONSULTING
General energy issues; energy efficiency; H.R.1682 - Energy Star Program Integrity Act
Removing Barriers to Allergy Diagnostic Testing Act of 2018
Client: THERMO FISHER SCIENTIFIC · Firm: FAEGRE BAKER DANIELS CONSULTING
Asthma policies and diagnostic allergy test coverage; H.R. 5541 - Removing Barriers to Allergy Diagnostic Testing Act of 2018
Removing Barriers to Allergy Diagnostic Testing Act of 2018
Client: THERMO FISHER SCIENTIFIC · Firm: FAEGRE BAKER DANIELS CONSULTING
Asthma policies and diagnostic allergy test coverage; H.R. 5541 - Removing Barriers to Allergy Diagnostic Testing Act of 2018
SUPPORT for Patients and Communities Act
Client: NATIONAL COUNCIL FOR BEHAVIORAL HEALTH · Firm: FAEGRE BAKER DANIELS CONSULTING
Ryan Haight Online Pharmacy Consumer Protection Act; H.R. 6 SUPPORT Act
SUPPORT for Patients and Communities Act
Client: NATIONAL COUNCIL FOR BEHAVIORAL HEALTH · Firm: FAEGRE BAKER DANIELS CONSULTING
Ryan Haight Online Pharmacy Consumer Protection Act; H.R. 6 SUPPORT Act
SUPPORT for Patients and Communities Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE BAKER DANIELS CONSULTING
Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs: H.R. 6 SUPPORT Act
RUSH Act of 2018
Client: AMERICAN TELEMEDICINE ASSOCIATION · Firm: FAEGRE BAKER DANIELS CONSULTING
HR 6502, The Reducing Unnecessary Senior Hospitalizations (RUSH) Act
RUSH Act of 2018
Client: AMERICAN TELEMEDICINE ASSOCIATION · Firm: FAEGRE BAKER DANIELS CONSULTING
HR 6502, The Reducing Unnecessary Senior Hospitalizations (RUSH) Act
Medicare Home Infusion Therapy Access Act of 2017
Client: IMMUNE DEFICIENCY FOUNDATION · Firm: FAEGRE BAKER DANIELS CONSULTING
Medicare coverage and payment for immune globulin (IG) treatments; Part B reimbursement issues; S. 1738 (Medicare Home Infusion Therapy Access Act); evaluation of IVIG Demonstration
Protecting Access to Medicare Act of 2014
Client: MYRIAD GENETICS, INC. · Firm: FAEGRE BAKER DANIELS CONSULTING
PL 113-93 (HR 4302) - Protecting Access to Medicare Act of 2014; implementation of changes to Medicare payment for clinical laboratory tests.
Protecting Access to Medicare Act of 2014
Client: MYRIAD GENETICS, INC. · Firm: FAEGRE BAKER DANIELS CONSULTING
PL 113-93 (HR 4302) - Protecting Access to Medicare Act of 2014; implementation of changes to Medicare payment for clinical laboratory tests.
Protecting Access to Medicare Act of 2014
Client: MYRIAD GENETICS, INC. · Firm: FAEGRE BAKER DANIELS CONSULTING
PL 113-93 (HR 4302) - Protecting Access to Medicare Act of 2014; implementation of changes to Medicare payment for clinical laboratory tests.
NATIONAL COUNCIL FOR BEHAVIORAL HEALTH via FAEGRE BAKER DANIELS CONSULTING
2020 · first_quarter · 1T
Ryan Haight Online Pharmacy Consumer Protection Act; H.R.6 SUPPORT for Patients and Communities Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN TELEMEDICINE ASSOCIATION via FAEGRE BAKER DANIELS CONSULTING
2020 · first_quarter · 1T
Telemedicine legislation including the RUSH Act; CONNECT Act; Ryan Haight Act; the National Suicide Hotline Designation Act; the Telemental Health Expansion Act
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, SENATE
IMMUNE DEFICIENCY FOUNDATION via FAEGRE BAKER DANIELS CONSULTING
2020 · first_quarter · 1T
Fiscal Year 2021 Labor, HHS Appropriations Act provisions focused on access to care and SCID newborn screening
Access to in-home IVIG including around current IVIG Bundled Payment Demonstration; S. 3457 and H.R. 6218 - Preserving Patient Access to Home Infusion Act; COVID-19 response and beneficiary access to care as a result of the emergency
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BLUEBIRD STRATEGIES (ON BEHALF OF THERMO FISHER SCIENTIFIC) via FAEGRE BAKER DANIELS CONSULTING
2020 · first_quarter · 1T
Asthma policies and diagnostic allergy test coverage; H.R. 2009 Removing Barriers to Allergy Diagnostic Testing Act of 2019; S. 2246 Allergy Testing Access Act of 2019
Asthma policies and diagnostic allergy test coverage; H.R. 2009 Removing Barriers to Allergy Diagnostic Testing Act of 2019; S. 2246 Allergy Testing Access Act of 2019
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL DOWN SYNDROME FOUNDATION via FAEGRE BAKER DANIELS CONSULTING
2020 · first_quarter · 1T
Fiscal Year 2021 Labor HHS appropriations for Down Syndrome Research; NIH research funding
Medicare/Medicaid legislation to promote quality treatment and coordinated care for people with Down Syndrome
Fiscal Year 2021 Labor HHS appropriations for Down Syndrome Research; NIH research funding
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
PARENT PROJECT MUSCULAR DYSTROPHY via FAEGRE BAKER DANIELS CONSULTING
2020 · first_quarter · 1T
NIH, CDC, and FDA issues relating to muscular dystrophy
Filing targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
BLUEBIRD STRATEGIES (ON BEHALF OF THERMO FISHER SCIENTIFIC) via FAEGRE BAKER DANIELS CONSULTING
2019 · fourth_quarter · 4A
Asthma policies and diagnostic allergy test coverage; H.R. 2009 Removing Barriers to Allergy Diagnostic Testing Act of 2019; S. 2246 Allergy Testing Access Act of 2019
Asthma policies and diagnostic allergy test coverage; H.R. 2009 Removing Barriers to Allergy Diagnostic Testing Act of 2019; S. 2246 Allergy Testing Access Act of 2019
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL DOWN SYNDROME FOUNDATION via FAEGRE BAKER DANIELS CONSULTING
2019 · fourth_quarter · 4A
Fiscal Year 2019 Labor HHS appropriations for Down Syndrome research
Support for Down Syndrome research funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUEBIRD STRATEGIES (ON BEHALF OF THERMO FISHER SCIENTIFIC) via FAEGRE BAKER DANIELS CONSULTING
2019 · fourth_quarter · RR
Asthma policies and diagnostic allergy test coverage; H.R. 2009 Removing Barriers to Allergy Diagnostic Testing Act of 2019; S. 2246 Allergy Testing Access Act of 2019
Asthma policies and diagnostic allergy test coverage; H.R. 2009 Removing Barriers to Allergy Diagnostic Testing Act of 2019; S. 2246 Allergy Testing Access Act of 2019
THERMO FISHER SCIENTIFIC via FAEGRE BAKER DANIELS CONSULTING
2019 · fourth_quarter · 4T
Fiscal Year 2019 labor HHS appropriations legislation; issues related to sepsis treatment and antibiotic stewardship.
Drug shortages
Asthma policies and diagnostic allergy test coverage; Removing Barriers to Allergy Diagnostics Testing Act of 2019
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PEAR THERAPEUTICS via FAEGRE BAKER DANIELS CONSULTING
2019 · fourth_quarter · 4T
Increase awareness of clinical use of FDA cleared prescription digital therapeutics.
Medicare coverage of FDA cleared prescription digital therapeutics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYRIAD GENETICS, INC. via FAEGRE BAKER DANIELS CONSULTING
2019 · fourth_quarter · 4T
PL 113-93 (H.R. 4302) - Protecting Access to Medicare Act of 2014; Implementation of changes to Medicare payment for clinical laboratory tests.
Draft legislation to regulate clinical labs under CLIA and FDA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNDERWRITERS LABORATORIES via FAEGRE BAKER DANIELS CONSULTING
2019 · fourth_quarter · Q4
General energy issues; energy efficiency
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COUNCIL FOR BEHAVIORAL HEALTH via FAEGRE BAKER DANIELS CONSULTING
2019 · fourth_quarter · Q4
Ryan Haight Online Pharmacy Consumer Protection Act; H.R.6 SUPPORT for Patients and Communities Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE BAKER DANIELS CONSULTING
2019 · fourth_quarter · Q4
Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs: H.R.6 SUPPORT for Patients and Communities Act
Medication safety, pharmacy regulation, and the opioid epidemic; Pharmacy regulation; Prescription drug monitoring programs; H.R.6 SUPPORT for Patients and Communities Act
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), SENATE
AMERICAN TELEMEDICINE ASSOCIATION via FAEGRE BAKER DANIELS CONSULTING
2019 · fourth_quarter · Q4
Telemedicine legislation including the RUSH Act; CONNECT Act; Ryan Haight Act; the National Suicide Hotline Designation Act; the Telemental Health Expansion Act
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
IMMUNE DEFICIENCY FOUNDATION via FAEGRE BAKER DANIELS CONSULTING
2019 · fourth_quarter · Q4
HR 2507 - Newborn Screening Saves Lives Reauthorization Act of 2019; Vaccine policy.
Medicare coverage and payment for immune globulin (IG) treatments; Part B reimbursement issues; implementation of home infusion services payment; coding and coverage of forms of primary immunodeficiency (PI) Disease; concerns regarding self-administered drugs list and home infusion payment
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
UNDERWRITERS LABORATORIES via FAEGRE BAKER DANIELS CONSULTING
2019 · third_quarter · Q3
General energy issues; energy efficiency
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE BAKER DANIELS CONSULTING
2019 · third_quarter · Q3
Pharmacy regulation; Prescription drug monitoring
Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs: H.R. 6 SUPPORT Act
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
AMERICAN TELEMEDICINE ASSOCIATION via FAEGRE BAKER DANIELS CONSULTING
2019 · third_quarter · Q3
Telemedicine legislation including the RUSH Act; CONNECT Act; Ryan Haight Act
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
NATIONAL COUNCIL FOR BEHAVIORAL HEALTH via FAEGRE BAKER DANIELS CONSULTING
2019 · third_quarter · Q3
Ryan Haight Online Pharmacy Consumer Protection Act; H.R. 6 SUPPORT Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THERMO FISHER SCIENTIFIC via FAEGRE BAKER DANIELS CONSULTING
2019 · third_quarter · Q3
Drug shortages
Fiscal Year 2019 labor HHS appropriations legislation; issues related to sepsis treatment and antibiotic stewardship.
Asthma policies and diagnostic allergy test coverage; Removing Barriers to Allergy Diagnostics Testing Act of 2019
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PEAR THERAPEUTICS via FAEGRE BAKER DANIELS CONSULTING
2019 · third_quarter · Q3
Increase awareness of clinical use of FDA cleared prescription digital therapeutics.
Medicare coverage of FDA cleared prescription digital therapeutics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYRIAD GENETICS, INC. via FAEGRE BAKER DANIELS CONSULTING
2019 · third_quarter · Q3
PL 113-93 (H.R. 4302) - Protecting Access to Medicare Act of 2014; Implementation of changes to Medicare payment for clinical laboratory tests.
Draft legislation to regulate clinical labs under CLIA and FDA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IMMUNE DEFICIENCY FOUNDATION via FAEGRE BAKER DANIELS CONSULTING
2019 · third_quarter · Q3
Medicare coverage and payment for immune globulin (IG) treatments; Part B reimbursement issues; implementation of home infusion services payment; coding and coverage of forms of primary immunodeficiency (PI) Disease; concerns regarding self-administered drugs list and home infusion payment
HR 2507 - Newborn Screening Saves Lives Reauthorization Act of 2019; Vaccine policy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
UNDERWRITERS LABORATORIES via FAEGRE BAKER DANIELS CONSULTING
2019 · second_quarter · Q2
General energy issues; energy efficiency
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IMMUNE DEFICIENCY FOUNDATION via FAEGRE BAKER DANIELS CONSULTING
2019 · second_quarter · Q2
HR 2507 - Newborn Screening Saves Lives Reauthorization Act of 2019; Vaccine policy.
Medicare coverage and payment for immune globulin (IG) treatments; Part B reimbursement issues; implementation of home infusion services payment; coding and coverage of forms of primary immunodeficiency (PI) Disease.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
THERMO FISHER SCIENTIFIC via FAEGRE BAKER DANIELS CONSULTING
2019 · second_quarter · Q2
Drug shortages
Asthma policies and diagnostic allergy test coverage; Removing Barriers to Allergy Diagnostics Testing Act of 2019
Fiscal Year 2019 labor HHS appropriations legislation; issues related to sepsis treatment and antibiotic stewardship.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PEAR THERAPEUTICS via FAEGRE BAKER DANIELS CONSULTING
2019 · second_quarter · Q2
Medicare coverage of FDA cleared prescription digital therapeutics.
Increase awareness of clinical use of FDA cleared prescription digital therapeutics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYRIAD GENETICS, INC. via FAEGRE BAKER DANIELS CONSULTING
2019 · second_quarter · Q2
Draft legislation to regulate clinical labs under CLIA and FDA.
PL 113-93 (H.R. 4302) - Protecting Access to Medicare Act of 2014; Implementation of changes to Medicare payment for clinical laboratory tests.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN TELEMEDICINE ASSOCIATION via FAEGRE BAKER DANIELS CONSULTING
2019 · second_quarter · Q2
Telemedicine legislation including the RUSH Act; CONNECT Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE BAKER DANIELS CONSULTING
2019 · second_quarter · Q2
Pharmacy regulation; Prescription drug monitoring
Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs: H.R. 6 SUPPORT Act
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
NATIONAL COUNCIL FOR BEHAVIORAL HEALTH via FAEGRE BAKER DANIELS CONSULTING
2019 · second_quarter · Q2
Ryan Haight Online Pharmacy Consumer Protection Act; H.R. 6 SUPPORT Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNDERWRITERS LABORATORIES via FAEGRE BAKER DANIELS CONSULTING
2019 · first_quarter · Q1
General energy issues; energy efficiency
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THERMO FISHER SCIENTIFIC via FAEGRE BAKER DANIELS CONSULTING
2019 · first_quarter · Q1
Fiscal Year 2019 labor HHS appropriations legislation; issues related to sepsis treatment and antibiotic stewardship.
Drug shortages
Asthma policies and diagnostic allergy test coverage; Removing Barriers to Allergy Diagnostics Testing Act of 2019
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
IMMUNE DEFICIENCY FOUNDATION via FAEGRE BAKER DANIELS CONSULTING
2019 · first_quarter · Q1
Patient access to medications; general overview of primary immunodeficiency (PI) community.
Medicare coverage and payment for immune globulin (IG) treatments; Part B reimbursement issues; implementation of home infusion services payment; coding and coverage of forms of primary immunodeficiency (PI) Disease.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PEAR THERAPEUTICS via FAEGRE BAKER DANIELS CONSULTING
2019 · first_quarter · Q1
Medicare coverage of FDA cleared prescription digital therapeutics.
Increase awareness of clinical use of FDA cleared prescription digital therapeutics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYRIAD GENETICS, INC. via FAEGRE BAKER DANIELS CONSULTING
2019 · first_quarter · Q1
PL 113-93 (H.R. 4302) - Protecting Access to Medicare Act of 2014; Implementation of changes to Medicare payment for clinical laboratory tests.
Draft legislation to regulate clinical labs under CLIA and FDA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE BAKER DANIELS CONSULTING
2019 · first_quarter · Q1
Pharmacy regulation; Prescription drug monitoring
Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs: H.R. 6 SUPPORT Act
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
AMERICAN TELEMEDICINE ASSOCIATION via FAEGRE BAKER DANIELS CONSULTING
2019 · first_quarter · Q1
Telemedicine legislation including the RUSH Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COUNCIL FOR BEHAVIORAL HEALTH via FAEGRE BAKER DANIELS CONSULTING
2019 · first_quarter · Q1
Ryan Haight Online Pharmacy Consumer Protection Act; H.R. 6 SUPPORT Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THERMO FISHER SCIENTIFIC via FAEGRE BAKER DANIELS CONSULTING
2018 · fourth_quarter · Q4
Drug shortage prevention and abuse-deterrent pseudophedrine.
Fiscal year 2019 VA and labor HHS appropriations legislation; issues related to sepsis treatment and antibiotic stewardship
Asthma policies and diagnostic allergy test coverage; H.R. 5541 - Removing Barriers to Allergy Diagnostic Testing Act of 2018
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PEAR THERAPEUTICS via FAEGRE BAKER DANIELS CONSULTING
2018 · fourth_quarter · Q4
Increase awareness of clinical use of FDA cleared prescription digital therapeutics
Medicare coverage of FDA cleared prescription digital therapeutics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYRIAD GENETICS, INC. via FAEGRE BAKER DANIELS CONSULTING
2018 · fourth_quarter · Q4
Draft legislation to regulate clinical labs under CLIA and FDA.
PL 113-93 (HR 4302) - Protecting Access to Medicare Act of 2014; implementation of changes to Medicare payment for clinical laboratory tests.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYRIAD GENETICS, INC. via FAEGRE BAKER DANIELS CONSULTING
2018 · third_quarter · 3A
PL 113-93 (HR 4302) - Protecting Access to Medicare Act of 2014; implementation of changes to Medicare payment for clinical laboratory tests.
Draft legislation to regulate clinical labs under CLIA and FDA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNDERWRITERS LABORATORIES via FAEGRE BAKER DANIELS CONSULTING
2018 · fourth_quarter · Q4
General energy issues; energy efficiency; H.R.1682 - Energy Star Program Integrity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE BAKER DANIELS CONSULTING
2018 · fourth_quarter · Q4
Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs: H.R. 6 SUPPORT Act
Pharmacy regulation; Prescription drug monitoring
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
NATIONAL COUNCIL FOR BEHAVIORAL HEALTH via FAEGRE BAKER DANIELS CONSULTING
2018 · fourth_quarter · Q4
Ryan Haight Online Pharmacy Consumer Protection Act; H.R. 6 SUPPORT Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN TELEMEDICINE ASSOCIATION via FAEGRE BAKER DANIELS CONSULTING
2018 · fourth_quarter · RR
HR 6502, The Reducing Unnecessary Senior Hospitalizations (RUSH) Act
HR 6502, The Reducing Unnecessary Senior Hospitalizations (RUSH) Act
IMMUNE DEFICIENCY FOUNDATION via FAEGRE BAKER DANIELS CONSULTING
2018 · fourth_quarter · Q4
Patient access to medications; access to insurance coverage; patient protections in AHCA and BCRA; health care reform
Medicare coverage and payment for immune globulin (IG) treatments; Part B reimbursement issues; S. 1738 (Medicare Home Infusion Therapy Access Act); evaluation of IVIG Demonstration
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
THERMO FISHER SCIENTIFIC via FAEGRE BAKER DANIELS CONSULTING
2018 · third_quarter · Q3
Fiscal year 2019 VA and labor HHS appropriations legislation; issues related to sepsis treatment and antibiotic stewardship
Asthma policies and diagnostic allergy test coverage; H.R. 5541 - Removing Barriers to Allergy Diagnostic Testing Act of 2018
Drug shortage prevention and abuse-deterrent pseudophedrine.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COUNCIL FOR BEHAVIORAL HEALTH via FAEGRE BAKER DANIELS CONSULTING
2018 · third_quarter · Q3
Ryan Haight Online Pharmacy Consumer Protection Act; H.R. 6 SUPPORT Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYRIAD GENETICS, INC. via FAEGRE BAKER DANIELS CONSULTING
2018 · third_quarter · Q3
Draft legislation to regulate clinical labs under CLIA and FDA.
PL 113-93 (HR 4302) - Protecting Access to Medicare Act of 2014; implementation of changes to Medicare payment for clinical laboratory tests.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PEAR THERAPEUTICS via FAEGRE BAKER DANIELS CONSULTING
2018 · third_quarter · Q3
Medicare coverage of FDA cleared prescription digital therapeutics
Increase awareness of clinical use of FDA cleared prescription digital therapeutics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE